Striving to Quit-Wisconsin Tobacco Quit Line

Not Applicable

Withdrawn

• Conditions: Smoking; Nicotine Dependence; Smoking Cessation
• Interventions: Behavioral: Incentives for abstinence and treatment engagement; Behavioral: Attendance incentive

• Registration Number: NCT01569477
• Lead Sponsor: University of Wisconsin, Madison

Brief Summary

This study is designed to test the hypotheses that incentives can increase both participation in smoking cessation treatment and resulting cessation rates when they are offered to Medicaid BadgerCare Plus members.

Detailed Description

Aim 1: To determine the extent to which contingent financial "treatment incentives" (i.e., incentives for biochemical verification visits, treatment engagement, and abstinence) versus "attendance incentives" (i.e., incentives for only attending the biochemical verification visits), increase rates of smoking cessation . Participants will be BadgerCare Plus tobacco users who enroll in Wisconsin Tobacco Quit Line (WTQL) services.

Aim 2: To determine the extent to which treatment incentives vs. attendance incentives increase rates of engagement in smoking cessation treatment through the WTQL when offered to BadgerCare Plus members who smoke.

Aim 3: To determine the cost-effectiveness of the smoking cessation program when paired with treatment incentives and when paired with attendance incentives.

Aim 4: To identify moderating and mediational effects regarding the clinical benefit of incentivized smoking treatment

Aim 5: To determine the reach of an incentivized smoking cessation treatment that depends upon primary care clinic staff, a fax-to-quit referral mechanism and a state quit line.

Study Timeline

• Study First Submitted: 2012-03-30
• Study First Submitted QC: 2012-03-30
• Study First Posted: 2012-04-03
• Study Start: 2012-09
• Primary Completion: 2013-03
• Study Completion: 2013-03
• Status Verified: 2016-12
• Last Update Submitted: 2016-12-05
• Last Update Posted: 2016-12-06

Recruitment & Eligibility

• Status: WITHDRAWN
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• enrollment in Wisconsin Medicaid (BadgerCare Plus)
• resides in study area (one of 25 counties)
• member of participating HMOs
• 18 or older
• English speaking
• has smoked daily (at least 5 cigarettes each day) over the last week
• willingness to attend visits at his/her PCC (primary care clinic) every 6 months (3 times over a 12 month period), provide urine samples, and complete follow-up phone calls
• willingness to inform the WTQL as to any change in address, phone number, clinic attended, or health plan.

Exclusion Criteria

• not enrolled in Wisconsin Medicaid (BadgerCare Plus)
• not reside in study area
• not a member participating HMOs
• less than 18 years of age
• not English speaking
• does not smoke daily (at least 5 cigarettes each day) over the last week
• not willing to attend visits at his/her PCC (primary care clinic) every 6 months (3 times over a 12 month period), provide urine samples, and complete follow-up phone calls.
• not willing to inform the WTQL as to any change in address, phone number, clinic attended, or health plan.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Treatment incentives	Incentives for abstinence and treatment engagement	Incentives for biochemical verification visits, treatment engagement, and abstinence
Attendance incentive	Attendance incentive	Incentives for only attending the biochemical verification visits

Primary Outcome Measures

Name	Time	Method
Abstinence from smoking	Measured 6 months after enrollment at follow-up assessment	The data will be the biochemically confirmed reports of abstinence for the past 7 days (i.e., 7-day point-prevalence abstinence)

Secondary Outcome Measures

Name	Time	Method
Engagement in treatment	Measured 12 months after enrollment at follow-up assessment	The primary analyses will compare number of calls completed
Cost-effectiveness	Measured 12 months after enrollment	The primary analysis will contrast the incremental costs of the treatment vs. attendance conditions by computing the Incremental Cost-Effectiveness Ratio (ICER) with regard to attaining 6-month abstinence.